Medication | Addiction Professional Magazine Skip to content Skip to navigation

Medication

Settlement clarifies discrimination for buprenorphine use

May 18, 2018  |  Julie Miller, Editor in Chief
article
A Legal Action Center expert says a recent settlement sets a precedent, indicating that refusing to treat individuals solely based on their addiction disorders will be considered discrimination.

FDA approves non-opioid for opioid withdrawal symptoms

May 17, 2018  |  Gary A. Enos, Editor
news
The Food and Drug Administration has approved the first non-opioid medication for the treatment of painful opioid withdrawal symptoms.

Compound shows promise for curbing alcohol withdrawal

May 10, 2018  |  Tom Valentino, Senior Editor
article
Scientists at the University of Texas at Austin are developing a drug compound that targets a receptor not previously linked with alcohol.

Research on endocannabinoids could uncover treatments for cocaine addiction

May 10, 2018  |  Gary A. Enos, Editor
news
Researchers will study the role of a binding protein in contributing to the effects of cocaine abuse on the brain.

Separate unit for opioid disorder treatment builds fellowship

May 7, 2018  |  Gary A. Enos, Editor
article
Caron Treatment Centers responded to patient concerns about isolation by establishing a treatment unit devoted exclusively to opioid use disorders.

Study explores challenge of initiating patient on injectable naltrexone

April 17, 2018  |  Gary A. Enos, Editor
article
New research offers hope for those who might assume it is too difficult to transition an opioid-dependent patient to injectable naltrexone in a community-based setting.

First non-opioid to treat withdrawal clears key hurdle

April 13, 2018  |  Alison Knopf, Contributing Writer
article
An advisory committee to the Food and Drug Administration (FDA) is recommending approval of lofexidine, which would offer an alternative to opioid medications for treatment of opioid withdrawal symptoms.

SAMHSA grants will encourage wider access to naloxone

April 12, 2018  |  Gary A. Enos, Editor
news
Methadone treatment programs and buprenorphine prescribers are among those eligible for federal grants to encourage wider distribution of opioid overdose reversal drugs.

Respect, not coddling, for buprenorphine patients

April 11, 2018  |  Sylvester Sviokla, MD
article
A physician in recovery sees patients soar with an assist from buprenorphine.

Rx Summit 18: Surgeon general underlines value of naloxone

April 9, 2018  |  Julie Miller, Editor in Chief
article
At the 2018 National Rx Drug Abuse & Heroin Summit, Surgeon General Jerome Adams, MD, underscored the federal strategy for the opioid crisis with a rare public health advisory issued from his office on the use of naloxone.

RX Summit 18: NIH unveils opioid-focused research initiative

April 4, 2018  |  Gary A. Enos, Editor
article
The new Helping to End Addiction Long-term (HELP) initiative could include collaborative demonstration projects in states hardest hit by the opioid epidemic.

Netflix film profiles society's appetite for Adderall

March 29, 2018  |  Gary A. Enos, Editor
news
"Take Your Pills" examines how pressures to excel have fueled demand for prescription stimulants.

Pages

Subscribe to Medication